Green Cross Health asks parties to promise pharmacists wider powers and better funding
Green Cross Health has written to all political parties asking them to promise wider treatment powers for pharmacists and better funding for pharmacies.
The company, which owns Unichem and Life Pharmacies, says rule changes to let pharmacists treat more common conditions would ease pressure on emergency departments and general practice, according to RNZ. Chief executive Rachael Newfield is fronting the call.
Green Cross Health speaks for more than 300 community pharmacies under the Unichem and Life Pharmacy brands. It owns shares in 83 pharmacies, and its pharmacists fill more than 38 million prescriptions a year.
The all-parties letter came a day after Green Cross Health backed an ACT proposal to give pharmacists wider powers, reported by The Post on 6 October. The company issued its open call to all parties on 7 October, as reported by RNZ.
In Wellington terms, that timing is familiar. Backing one party's idea and then pitching to all parties is standard work before an election. It seeks promises for party manifestos, rather than a bid for Budget money alone.
The funding background is already moving. Health NZ says New Zealand is expanding the range of funded clinical services, health checks and treatments, not just dispensing, that can be delivered through community pharmacy, according to Health NZ. The June 2026 Expanded Pharmacy Services decision led to Health NZ funding consultations for women aged under 25, according to Pharmac.
Green Cross Health's pharmacy division lifted operating revenue by 2 percent to $380.2 million for the year to 31 March 2026, according to NZ Doctor. In its full-year results in May, the company said "significant opportunity remains to expand pharmacy scope and improve funding arrangements," according to NZX.
The broader context here is process and pay. Scope is regulation, the rules for what pharmacists can do. Funding is commissioning, how Health NZ orders and pays for those services. A party can support wider powers in principle and still leave the service details and fee levels to later work. Those settings decide whether pharmacies take up the work.
Looking at what this means for the parties, the company has put two questions to them. One is which conditions and treatments they would add to pharmacist scope. The other is how they would pay for those consultations. The June decision on consultations for women aged under 25 shows how tightly a funded pharmacy service can be defined.
In my view, advisers writing the replies will need to be specific. A general promise to expand scope leaves open timetables, prescribing rights and training. A general promise on funding leaves open payment levels, who qualifies and how services are delivered. People in the sector will read the detail.
